SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-23-001678
Filing Date
2023-03-22
Accepted
2023-03-22 17:00:34
Documents
74
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K phio_i10k-123122.htm   iXBRL 10-K 1132754
2 CLINICAL CO-DEVELOPMENT AGREEMENT phio_ex1002.htm EX-10.2 302430
3 SEPARATION AGREEMENT, DATE MAY 5, 2022, BY AND BETWEEN PHIO PHARMACEUTICALS CORP phio_ex1011.htm EX-10.11 50202
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_ex2301.htm EX-23.1 2040
5 CERTIFICATION phio_ex3101.htm EX-31.1 11301
6 CERTIFICATION phio_ex3201.htm EX-32.1 4985
7 GRAPHIC image_001.jpg GRAPHIC 25361
  Complete submission text file 0001683168-23-001678.txt   5621497

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE phio-20221231.xsd EX-101.SCH 38886
9 XBRL CALCULATION FILE phio-20221231_cal.xml EX-101.CAL 51965
10 XBRL DEFINITION FILE phio-20221231_def.xml EX-101.DEF 162037
11 XBRL LABEL FILE phio-20221231_lab.xml EX-101.LAB 332430
12 XBRL PRESENTATION FILE phio-20221231_pre.xml EX-101.PRE 269392
68 EXTRACTED XBRL INSTANCE DOCUMENT phio_i10k-123122_htm.xml XML 677485
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 23753592
SIC: 2834 Pharmaceutical Preparations